Patent 8735545 was granted and assigned to Xencor on May, 2014 by the United States Patent and Trademark Office.
The present invention relates to Fc variants having increased affinity for FcγRIIc, methods for their generation, Fc polypeptides comprising optimized Fc variants, and methods for using optimized Fc variants.